Bas Boekestijn

518 total citations
18 papers, 202 citations indexed

About

Bas Boekestijn is a scholar working on Oncology, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Bas Boekestijn has authored 18 papers receiving a total of 202 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Surgery and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Bas Boekestijn's work include Pancreatic and Hepatic Oncology Research (9 papers), Pancreatitis Pathology and Treatment (5 papers) and Cancer Genomics and Diagnostics (4 papers). Bas Boekestijn is often cited by papers focused on Pancreatic and Hepatic Oncology Research (9 papers), Pancreatitis Pathology and Treatment (5 papers) and Cancer Genomics and Diagnostics (4 papers). Bas Boekestijn collaborates with scholars based in Netherlands, United States and Greece. Bas Boekestijn's co-authors include Bert A. Bonsing, Martin N.J.M. Wasser, Jeanin E. van Hooft, J. Sven D. Mieog, Hans F. A. Vasen, Derk C.F. Klatte, Monique E. van Leerdam, Akin Inderson, Saskia Luelmo and Jurjen J. Boonstra and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Scientific Reports.

In The Last Decade

Bas Boekestijn

17 papers receiving 198 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bas Boekestijn Netherlands 7 132 70 59 29 27 18 202
Aryeh J. Price Canada 9 59 0.4× 16 0.2× 42 0.7× 40 1.4× 50 1.9× 10 185
Niklas Pal Sweden 8 43 0.3× 46 0.7× 29 0.5× 61 2.1× 28 1.0× 15 210
Sandra S. Zaky United States 5 146 1.1× 53 0.8× 53 0.9× 37 1.3× 18 0.7× 14 285
Nicole Tsim United Kingdom 7 181 1.4× 148 2.1× 86 1.5× 106 3.7× 59 2.2× 13 375
Chihiro Kanehira Japan 7 84 0.6× 55 0.8× 25 0.4× 14 0.5× 48 1.8× 25 193
Sara E. Martin del Campo United States 9 85 0.6× 92 1.3× 75 1.3× 90 3.1× 44 1.6× 19 284
Alan Heimann United States 10 56 0.4× 38 0.5× 79 1.3× 29 1.0× 15 0.6× 27 234
Ningning Li China 8 97 0.7× 15 0.2× 71 1.2× 70 2.4× 25 0.9× 27 240

Countries citing papers authored by Bas Boekestijn

Since Specialization
Citations

This map shows the geographic impact of Bas Boekestijn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bas Boekestijn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bas Boekestijn more than expected).

Fields of papers citing papers by Bas Boekestijn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bas Boekestijn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bas Boekestijn. The network helps show where Bas Boekestijn may publish in the future.

Co-authorship network of co-authors of Bas Boekestijn

This figure shows the co-authorship network connecting the top 25 collaborators of Bas Boekestijn. A scholar is included among the top collaborators of Bas Boekestijn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bas Boekestijn. Bas Boekestijn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hooft, Jeanin E. van, Bas Boekestijn, Bert A. Bonsing, et al.. (2024). Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer. Familial Cancer. 23(3). 323–339. 5 indexed citations
2.
Timmerhuis, Hester C., Jesse V. Groen, Marc G. Besselink, et al.. (2024). Splanchnic vein thrombosis in necrotizing pancreatitis: a post-hoc analysis of a nationwide prospective cohort. HPB. 26(4). 548–557. 2 indexed citations
3.
Boekestijn, Bas, et al.. (2024). Fluorescence-guided minimally-invasive resection of abdominal paragangliomas using indocyanine green. Scientific Reports. 14(1). 1 indexed citations
4.
Inderson, Akin, Bas Boekestijn, Bert A. Bonsing, et al.. (2024). The Added Value of Blood Glucose Monitoring in High-Risk Individuals Undergoing Pancreatic Cancer Surveillance. Pancreas. 53(7). e566–e572. 1 indexed citations
5.
6.
Boekestijn, Bas, Shirin Feshtali, Hans F. A. Vasen, et al.. (2024). Screening for pancreatic cancer in high-risk individuals using MRI: optimization of scan techniques to detect small lesions. Familial Cancer. 23(3). 295–308. 6 indexed citations
7.
Boekestijn, Bas, Alexander Broersen, Minneke J. Coenraad, et al.. (2023). Intraprocedural assessment of ablation margins using computed tomography co-registration in hepatocellular carcinoma treatment with percutaneous ablation: IAMCOMPLETE study. Diagnostic and Interventional Imaging. 105(2). 57–64. 5 indexed citations
8.
Boekestijn, Bas, et al.. (2023). Unravelling the skillset of point-of-care ultrasound: a systematic review. The Ultrasound Journal. 15(1). 19–19. 5 indexed citations
9.
Groen, Jesse V., Hester C. Timmerhuis, Marc G. Besselink, et al.. (2023). Therapeutic anticoagulation for splanchnic vein thrombosis in acute pancreatitis: A national survey and case-vignette study. World Journal of Gastroenterology. 29(21). 3328–3340. 4 indexed citations
10.
Klatte, Derk C.F., Bas Boekestijn, Friedo W. Dekker, et al.. (2023). Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Analysis. Gastroenterology. 164(7). 1223–1231.e4. 35 indexed citations
11.
Klatte, Derk C.F., Bas Boekestijn, Friedo W. Dekker, et al.. (2023). Surveillance for pancreatic cancer in high-risk individuals leads to improved outcomes: a propensity score matched analysis. Pancreatology. 23. e17–e18.
12.
Groen, Jesse V., Frederikus A. Klok, Bas Boekestijn, et al.. (2022). Therapeutic Anticoagulation for Splanchnic Vein Thrombosis in Acute Pancreatitis: A Systematic Review and Meta-Analysis. HPB. 24. S247–S247. 1 indexed citations
13.
Klatte, Derk C.F., Bas Boekestijn, Martin N.J.M. Wasser, et al.. (2022). Pancreatic Cancer Surveillance in Carriers of a Germline CDKN2A Pathogenic Variant: Yield and Outcomes of a 20-Year Prospective Follow-Up. Journal of Clinical Oncology. 40(28). 3267–3277. 60 indexed citations
14.
Groen, Jesse V., Frederikus A. Klok, Bas Boekestijn, et al.. (2021). Therapeutic anticoagulation for splanchnic vein thrombosis in acute pancreatitis: A systematic review and meta-analysis. Pancreatology. 22(2). 235–243. 21 indexed citations
15.
Burgmans, Mark C., Lioe‐Fee de Geus‐Oei, Bas Boekestijn, et al.. (2020). Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study. Annals of Surgical Oncology. 28(2). 1130–1141. 22 indexed citations
16.
Boekestijn, Bas, Shirin Feshtali, Isaura S. Ibrahim, et al.. (2020). MRI screening in hereditary pancreatic cancer: value of various sequences in the detection of early pancreatic cancer. Pure Amsterdam UMC. 3. 16–16. 3 indexed citations
17.
Vasen, Hans F. A., Bas Boekestijn, Isaura S. Ibrahim, et al.. (2019). Dilatation of the main pancreatic duct as first manifestation of small pancreatic ductal adenocarcinomas detected in a hereditary pancreatic cancer surveillance program. HPB. 21(10). 1371–1375. 10 indexed citations
18.
Boekema, Bouke K. H. L., Bas Boekestijn, & Roelf S. Breederveld. (2014). Evaluation of saline, RPMI and DMEM/F12 for storage of split-thickness skin grafts. Burns. 41(4). 848–852. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026